IRCT20130924014752N5 IRCT 2018-03-05 Endocine Research Center of Isfahan University of Medical Science Acarbose effect in metabolic syndrome Assessment of the effect of Acarbose on anthropometric indices and metabolic markers in obese women whit metabolic syndrome 2017-03-01 anticipated 80 Complete https://irct.ir/trial/14287 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: People who, Blinding description: One of our colleagues is selected to attach a blue or green tag on drug or placebo boxes.Only two people know about the meaning of color .If participant has any adverse ,they refer to this colleague who knows about placebo or drug administration and he decide to continue or finish study. 3 Obesity. Intervention 1: Intervention group: acarbose is administrated for three month with 300 mg .At first it is prescribed with low dose 25 mg three times a day,and gradually placebo dose is increased till 100 mg for each meal. Intervention 2: Control group:placebo is administrated for three month with 300 mg daily .the dose of placebo is increased gradually from 25 mg to 100mg three times for each meal . Yes - There is a plan to make this available What will be shared: we will publish all kind of information about our study When: after published it is available for all to get it To whom: researcher and academic people and people who enrolled in study Conditions: for improvement of health care and treatment Where to obtain: we will publish it in academic journal then others can use it How to obtain: the academic person can email to author to get it Comments: